Keywords: astrazeneca, continue, invest, japan, despite, cost-cutting, program

AstraZeneca will continue to invest in Japan, despite cost-cutting program

Article | 20 October 2008

Print This

Anglo-Swedish drug major AstraZeneca says it will continue to invest resources in Japan despite its global restructuring plan.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in